GYRE THERAPEUTICS, INC. (GYRE) › Net IncomeGYRE THERAPEUTICS, INC. (GYRE) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$39.40M2010: $10.90M2011: -$8.53M2012: -$7.00M2013: -$9.97M2014: -$6.61M2015: -$14.76M2016: -$16.95M2017: -$21.56M2018: -$30.05M2019: -$55.18M2020: -$56.24M2021: -$87.93M2022: $4.31M2023: -$85.48M2024: $17.90M2025: $9.88M$9.88M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$9.88M-44.8%2024$17.90M+120.9%2023-$85.48M-2081.5%2022$4.31M+104.9%2021-$87.93M-56.4%2020-$56.24M-1.9%2019-$55.18M-83.6%2018-$30.05M-39.4%2017-$21.56M-27.2%2016-$16.95M-14.8%2015-$14.76M-123.2%2014-$6.61M+33.6%2013-$9.97M-42.4%2012-$7.00M+18.0%2011-$8.53M-178.3%2010$10.90M+127.7%2009-$39.40M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share